heartlinx Medical News about Type; 2 Diabetic Patients; Prevention of Cardiovascular Disease

Email This Article

Save in My Library

Free Abstract

Zaman Huri H et al. - Many of the eligible patients still do not receive antiplatelet therapy, particularly in primary prevention of cardiovascular disease. Measures should be taken to ensure that type 2 diabetes mellitus patients receive the antiplatelet therapy and hence prevent macrovascular complications.

--- CLINICAL PHARMACOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Treatment of Atrial Fibrillation and Atrial Flutter
Cardiology In Review, 08/21/08

Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy
Blood Pressure, 09/15/08

Angiotensin Receptor Blockers: Current Status and Future Prospects
American Journal of Medicine, 08/25/08

...All of Clinical Pharmacology

--- PREVENTIVE TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Depression and Coronary Heart Disease. Recommendations for Screening, Referral, and Treatment
Circulation, 09/30/08

Peripheral arterial disease and isolated systolic hypertension
Journal of Human Hypertension, 10/03/08

Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes
Heart, 09/18/08

...All of Preventive

Sponsor

--- VASCULAR MEDICINE TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Angiotensin Receptor Blockers: Current Status and Future Prospects
American Journal of Medicine, 08/25/08

Kawasaki Disease in Children
Heart, 09/17/08

Cryptogenic stroke and patent foramen ovale
Current Opinion in Cardiology, 10/08/08

...All of Vascular Medicine